Characterizing Burnout in Health Professionals: Insights from the BEATS Study in Portugal

By João L. Carapinha

January 27, 2026

Burnout Health Professionals: Join the BEATS Study Call

Burnout health professionals in Portugal are invited to participate in the BEATS study, an initiative by the Portuguese Laboratory for Healthy Work Environments. Titled “BEATS – Burnout, Expectativas e Ambientes de Aprendizagem e Trabalhos Saudáveis” (Burnout, Expectations, and Healthy Learning and Work Environments), it characterizes burnout health professionals and examines workplace ecosystems as protective or risk factors. Collaboration with the Ordem dos Farmacêuticos urges pharmacists’ involvement for representativeness, using an anonymous 15-minute questionnaire for academic purposes.

Workplace ecosystems profoundly influence burnout health professionals experience, acting as safeguards or amplifiers. The BEATS study explores these dynamics in Portuguese health settings, analyzing environmental factors. It targets active practitioners, spotlighting pharmacists to capture profession-specific trends. This ecosystem lens promotes tailored interventions, blending organizational and worker contexts beyond individual evaluations.

The BEATS study’s questionnaire can be completed in 15 minutes by health professionals in Portugal. It stresses sincere responses with no right or wrong answers, upholding anonymity and confidentiality for research only. Participants can opt in or out freely. Led by Prof.ª Doutora Tânia Gaspar from SPIC/Universidade Lusófona, it meets ethical norms, offers clarification contacts, and falls under National Data Protection Authority oversight—ensuring robust burnout data without privacy risks.

BEATS will likely lead to occupational health costs in Portugal. By pinpointing modifiable ecosystems, it guides retention-boosting interventions, curbing absenteeism and turnover in roles like pharmacy. Results could back modeling of policy interventions towards healthy environments, offsetting healthcare spends and aligning with preventive trends for sustainable healthcare delivery.

Reference url

Recent Posts

Enhertu Breast Cancer Treatment Gains FDA Approval in Neoadjuvant and Adjuvant Settings

By João L. Carapinha

May 18, 2026

Enhertu breast cancer treatment has secured FDA approval for neoadjuvant use in adults with HER2-positive Stage II or III disease before surgery, followed by taxane plus trastuzumab and pertuzumab, and for adjuvant therapy in patients with residual invasive disease after prior trastuzumab-based r...
Pharmaceutical Onshoring Agreements: Navigating Tariff Relief and National Security Policies

By João L. Carapinha

The US Bureau of Industry and Security published formal procedures enabling manufacturers of patented pharmaceutical products to apply for company-specific pharmaceutical onshoring agreements with the Department of Commerce. These agreements allow qualifying firms to secure a reduced Section 232 ...
Dynamic Risk Stratification in Thromboembolism Prevention for Cancer Patients

By João L. Carapinha

Dynamic risk stratification enables more precise forecasting of venous thromboembolism risk in cancer patients by continuously updating predictions as new clinical data emerge. A transformer-based deep learning model was developed using longitudinal electronic health records from the U.S. Veteran...